Strategic partnerships SkinCure Oncology collaborates with dermatologists and Mohs surgeons to bring advanced, noninvasive image-guided SRT to physician offices, presenting a clear channel for expanding a distributor or integration partnerships with dermatology practices and cancer centers.

Revenue growth With reported revenue between 50 and 100 million and a growing footprint in image-guided SRT, there is opportunity to cross-sell complementary services, training packages, and service-level agreements to incumbent customers and expanding practices.

Technology enablement The Sensus SRT-100 Vision platform with high-frequency ultrasound imaging positions SkinCure as a tech-forward solution; selling opportunities exist for hardware scaling, maintenance contracts, cloud-based analytics, and integration with practice management systems.

Legal and risk awareness Recent lawsuits around contract disputes indicate a need for clear commercial terms, service level guarantees, and predictable pricing models when onboarding new practices, presenting a chance to offer robust contract frameworks and compliance support.

Market expansion Recent expansion activity such as partnering with Easton Dermatology and the launch of GentleBeam signals momentum in dermatology networks; target similarly positioned mid-sized clinics and regional chains seeking noninvasive skin cancer treatment capabilities.